Choosing between Henry Meds and PlushCare for weight loss involves evaluating specialized, affordable GLP-1 access against complete primary care integration and insurance-based delivery. Henry Meds launched in 2021 as a focused weight loss platform offering some of the market's most affordable semaglutide and tirzepatide through asynchronous consultations with obesity medicine specialists, optimized for uninsured or cash-pay patients. PlushCare started in 2014 as a full-service primary care telehealth provider offering weight loss as one component of complete medical services through live video consultations with board-certified primary care physicians, operating primarily through insurance billing. This comparison examines treatment approaches, pricing structures, insurance considerations, consultation formats, clinical expertise models, service integration, and patient fit to help you determine which platform aligns with your insurance status, budget constraints, healthcare needs, and whether you prioritize specialized cost-effective weight loss or integrated primary care management including obesity treatment.
Platform Overview
Henry Meds launched in 2021 as a specialized telehealth platform exclusively focused on affordable weight loss treatment through GLP-1 medications. The company has positioned itself as one of the most cost-effective providers of semaglutide and tirzepatide, serving patients nationwide through board-certified healthcare providers with obesity medicine expertise. Henry Meds operates with transparent pricing, streamlined consultation processes, and emphasis on removing cost barriers to breakthrough weight loss medications while maintaining appropriate medical supervision. The platform has grown rapidly by addressing the significant affordability gap preventing many patients from accessing expensive GLP-1 therapies, with HIPAA-compliant operations serving all 50 states, according to
FDA semaglutide safety information, according to
GoodRx medication pricing data.
PlushCare launched in 2014 as a full-service primary care telehealth platform offering complete medical services beyond specialty treatments. The platform connects patients with board-certified primary care physicians for acute care, chronic disease management, preventive medicine, mental health services, and specialty treatments including weight loss. PlushCare operates as a virtual primary care provider accepting most major insurance plans, with physicians licensed to treat patients across all 50 states. The platform provides video consultations (synchronous telemedicine) rather than asynchronous messaging, offering more traditional doctor-patient interactions through digital channels. PlushCare has established itself as a premium primary care telehealth option with complete service breadth.
Weight Loss Treatment Approach
Henry Meds GLP-1 Specialization: Henry Meds exclusively focuses on obesity treatment through GLP-1 receptor agonist medications including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). The platform provides both branded and compounded formulations depending on availability and patient preference, following evidence-based protocols from the
American Association of Clinical Endocrinology. Henry Meds physicians specialize in obesity medicine with concentrated expertise in GLP-1 therapy optimization, side effect management, and treatment customization. The asynchronous consultation model enables efficient, affordable access while maintaining appropriate medical oversight through secure messaging and periodic check-ins.
PlushCare Primary Care Weight Loss Model: PlushCare offers weight loss treatment as one component of complete primary care services, providing GLP-1 medications through board-certified primary care physicians. The platform conducts live video consultations lasting 15-30 minutes, offering more traditional synchronous doctor visits compared to asynchronous messaging models. PlushCare physicians can prescribe semaglutide, tirzepatide, and other weight loss medications when clinically appropriate, integrated with broader primary care management. This approach enables coordination between weight loss treatment and other health concerns, complete metabolic screening, and holistic primary care oversight of obesity treatment within the context of overall health management.
Clinical Efficacy and Approach Differences: Both platforms provide access to medications with well-established efficacy. FDA Wegovy prescribing information demonstrates semaglutide 2.4mg produces average weight loss of 12.4% body weight over 68 weeks.
FDA Zepbound label shows tirzepatide achieving 15-20.9% weight loss depending on dose. Henry Meds offers specialized obesity medicine expertise with asynchronous consultations optimized for cost efficiency, while PlushCare provides primary care physician oversight with synchronous video visits and integration with complete primary care services. The medications deliver equivalent results; differences lie in specialist versus generalist approach, consultation format, and service integration model.
Pricing and Insurance Comparison
Henry Meds Affordable Cash-Pay Model: Henry Meds operates with some of the market's lowest pricing for legitimate GLP-1 access, with monthly medication costs of $197-297/month for compounded semaglutide and tirzepatide. The platform charges a $49 one-time consultation fee for initial physician evaluation. Henry Meds primarily operates as a cash-pay service with transparent pricing designed to be accessible for uninsured patients or those whose insurance does not cover weight loss medications. HSA/FSA payments are accepted, enabling use of pre-tax health savings dollars. The platform is expanding insurance acceptance for consultations but maintains focus on affordable cash pricing. Annual costs for uninsured patients typically range from $2,364-3,564, positioning Henry Meds among the lowest-cost legitimate medical providers.
PlushCare Insurance-First Pricing: PlushCare operates primarily through insurance billing, accepting most major insurance plans including Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. For insured patients, visit costs typically equal insurance copays ($15-50 per visit depending on plan). Without insurance, PlushCare charges $99-149 per video consultation. Medication costs are separate and depend on whether insurance covers the specific GLP-1 medication—Wegovy or Zepbound when covered may cost $0-50/month with insurance, while uninsured patients pay pharmacy prices ($900-1,300/month for brand medications) or compounded formulations ($200-400/month). PlushCare model works best for patients with good insurance coverage; uninsured patients face higher costs than specialized cash-pay platforms.
Cost-Value Assessment: For uninsured patients or those without insurance coverage for weight loss medications, Henry Meds provides dramatically superior value with all-in costs of $197-297/month compared to PlushCare's $99-149 per consultation plus $200-400/month for compounded medications (total $299-549/month uninsured). For well-insured patients whose plans cover both consultations and GLP-1 medications, PlushCare may deliver better value with copay-only costs potentially lower than Henry Meds cash pricing.
Health Affairs research on telehealth pricing demonstrates that optimal platform choice depends heavily on insurance status and coverage specifics—specialized cash-pay platforms like Henry Meds serve uninsured markets effectively, while insurance-accepting platforms like PlushCare benefit well-insured patients with complete coverage.
Medical Consultation Format
Henry Meds Asynchronous Messaging Model: Henry Meds utilizes asynchronous telemedicine where patients complete detailed health questionnaires and communicate with physicians through secure messaging rather than live video appointments. Patients submit medical history, current medications, health concerns, and treatment goals through written forms. Physicians review this information and respond with medical recommendations, prescriptions, and treatment plans typically within 24-48 hours. Follow-up questions and ongoing management occur through continued asynchronous messaging. This model eliminates appointment scheduling, wait times, and real-time availability constraints, enabling efficient, affordable service delivery. Many patients prefer the convenience of not needing scheduled appointments.
PlushCare Synchronous Video Consultations: PlushCare operates with traditional synchronous telemedicine through live video appointments scheduled in advance. Patients book 15-30 minute video consultations with board-certified physicians, conducting real-time face-to-face conversations via secure video platform. This format mirrors traditional in-person doctor visits adapted for telehealth, enabling dynamic conversation, immediate clarification of questions, real-time physical assessment guidance, and direct interpersonal interaction with physicians. Video visits require scheduling availability on both patient and physician sides, with appointments typically available within days. Many patients prefer live interaction for complex medical discussions or those valuing personal connection with providers.
Format Preference Considerations: Asynchronous messaging (Henry Meds) offers maximum scheduling flexibility, eliminates wait times, allows thoughtful written communication, and reduces costs through operational efficiency. Synchronous video (PlushCare) provides immediate interactive dialogue, enables nuanced discussion of complex medical issues, creates personal physician-patient relationships, and mirrors traditional care delivery more closely. JAMA research on telemedicine modalities suggests both approaches deliver clinically appropriate care for most conditions when properly implemented, with patient preference and clinical complexity determining optimal format. For straightforward GLP-1 prescriptions, asynchronous messaging suffices and costs less; for patients wanting interactive discussion or managing complex medical situations, synchronous video provides advantages worth higher costs.
Clinical Expertise and Specialization
Henry Meds Obesity Medicine Specialization: Henry Meds physicians focus exclusively on weight loss treatment, developing deep expertise in obesity medicine, GLP-1 therapy optimization, medication selection, dosing strategies, side effect management, and weight loss treatment customization. Providers follow guidelines from the
Obesity Medicine Association and stay current with rapidly evolving GLP-1 research and clinical best practices. The exclusive focus enables concentrated knowledge application to every patient interaction, with physicians becoming highly experienced in the specific challenges, nuances, and optimization opportunities in GLP-1 therapy. This specialization particularly benefits complex cases requiring expert medication management or patients experiencing unusual side effects or treatment complications.
PlushCare Primary Care Generalist Model: PlushCare employs board-certified primary care physicians trained in complete medical care across diverse conditions—acute illness, chronic disease management, preventive medicine, mental health, and specialty treatments including obesity. Primary care training provides broad medical knowledge rather than deep specialization in any single area. PlushCare physicians can appropriately prescribe GLP-1 medications and manage straightforward weight loss cases, though they may have less concentrated expertise in obesity medicine nuances compared to specialists focusing exclusively on weight management. The generalist model excels at coordinating care across multiple health domains and identifying interconnections between weight and other health conditions.
Specialist vs Generalist Trade-offs: Henry Meds specialized obesity medicine focus provides advantages for complex weight loss cases, optimization of treatment protocols, advanced side effect management, and deep GLP-1 expertise. PlushCare primary care model offers complete health oversight, identification of obesity-related comorbidities, coordination with other health concerns, and holistic medical management beyond weight alone. New England Journal of Medicine research on specialist versus generalist outcomes suggests specialists often achieve superior results for complex cases within their domain, while generalists excel at coordinating complete care across multiple conditions. For focused, expert weight loss treatment, Henry Meds specialization provides advantages; for patients wanting integrated primary care management of obesity within overall health context, PlushCare generalist coordination offers benefits.
Service Scope and Platform Integration
Henry Meds Single-Focus Platform: Henry Meds exclusively provides weight loss treatment through GLP-1 medications without additional health services. This narrow focus enables operational optimization, cost efficiency, and concentrated clinical expertise in obesity treatment. Patients needing care for conditions beyond weight loss must establish separate relationships with primary care providers or other specialists. Henry Meds operates as a specialized solution for one specific health need, excelling at that focused service without attempting complete healthcare delivery. The platform provides what it does exceptionally well—affordable, expert weight loss treatment—without expanding into areas outside its core competency.
PlushCare Complete Primary Care Platform: PlushCare serves as a complete primary care provider offering acute illness treatment (infections, injuries, rashes), chronic disease management (diabetes, hypertension, thyroid disorders), preventive care (annual physicals, health screenings), mental health services (depression, anxiety treatment), prescription management for diverse conditions, lab test ordering and interpretation, specialist referrals, and specialty treatments including weight loss. This breadth enables complete healthcare delivery through one provider network, with medical records consolidated and care coordinated across health domains. For patients without established primary care, PlushCare can serve as primary medical home addressing diverse health needs beyond weight management.
Service Integration Benefits: For patients needing only weight loss medication, Henry Meds focused approach provides exactly what's required at optimal cost without unnecessary complexity. For patients seeking telehealth primary care or those with multiple health concerns requiring coordinated management, PlushCare complete platform delivers significant convenience and potentially better care coordination. Journal of General Internal Medicine research on integrated care demonstrates that for patients with multiple chronic conditions or complex health profiles, complete primary care coordination improves outcomes and reduces fragmented care. PlushCare ability to manage obesity treatment within context of overall health, screen for comorbidities, and coordinate across conditions provides meaningful value for patients with broader healthcare needs beyond isolated weight loss.
Target Patient and Use Case Fit
Henry Meds Optimal Patient Profile: Henry Meds serves patients seeking the most affordable access to GLP-1 weight loss medications with specialized obesity medicine expertise. The platform excels for uninsured patients or those whose insurance does not cover weight loss medications, cost-conscious individuals prioritizing price optimization, patients comfortable with asynchronous messaging consultations, those needing exclusively weight loss treatment without additional healthcare services, and individuals valuing specialized rather than generalist medical management. Henry Meds fits patients with established primary care elsewhere who need only specialized weight loss treatment, or those for whom cost represents primary consideration in accessing GLP-1 therapy, according to
FDA semaglutide safety information, according to
GoodRx medication pricing data, according to
Kaiser Family Foundation coverage analysis.
PlushCare Optimal Patient Profile: PlushCare serves well-insured patients whose plans cover telemedicine consultations and potentially GLP-1 medications, individuals seeking complete primary care including weight management as one component, patients preferring live video interactions with physicians over asynchronous messaging, those needing coordinated care across multiple health concerns, patients without established primary care seeking virtual medical home, and individuals valuing integrated health management over cost optimization. PlushCare fits patients with good insurance coverage, those managing multiple health conditions benefiting from coordinated primary care, or individuals prioritizing complete medical oversight over specialized but isolated weight loss treatment.
Insurance and Service Scope Determine Fit: The Henry Meds versus PlushCare decision depends primarily on insurance status and service scope needs. Uninsured patients save dramatically with Henry Meds ($197-297/month all-in versus PlushCare $299-549/month uninsured total costs). Well-insured patients with coverage for telemedicine and GLP-1 medications may find PlushCare provides better value through copay-only access ($15-100/month potentially). Patients needing only weight loss treatment benefit from Henry Meds specialized focus and cost optimization. Patients needing or desiring complete primary care benefit from PlushCare integrated platform managing obesity within broader health context. The optimal choice aligns with insurance status, budget constraints, consultation format preference, and whether specialized weight loss focus or complete primary care integration better serves individual healthcare needs.
How We Tested Henry Meds vs PlushCare
Our Comparison Methodology
This comparison is based on complete analysis of treatment approaches, pricing models, insurance considerations, consultation formats, clinical expertise, service scope, and patient fit from both Henry Meds and PlushCare, supplemented by peer-reviewed research on obesity treatment, telemedicine modalities, and specialist versus generalist care models.
Clinical Evidence: Weight loss treatment recommendations reference FDA-approved GLP-1 medication labels including Wegovy (semaglutide) and Zepbound (tirzepatide), clinical guidelines from the American Association of Clinical Endocrinology, and standards from the Obesity Medicine Association. Information on medication efficacy and clinical management reflects established medical evidence for GLP-1 therapies.
Research Foundation: Analysis incorporates peer-reviewed research from Health Affairs on telehealth pricing models and insurance considerations, JAMA research on asynchronous versus synchronous telemedicine effectiveness, New England Journal of Medicine research on specialist versus generalist care outcomes, and Journal of General Internal Medicine research on integrated primary care benefits. These sources inform assessment of consultation format effectiveness, clinical expertise implications, integrated care value, and insurance-based versus cash-pay service models.
Pricing Analysis: Pricing information verified through direct platform review as of January 2026, including consultation fees, medication costs, insurance acceptance policies, and total treatment costs for both insured and uninsured scenarios. Cost comparisons account for different payment models—cash-pay optimization (Henry Meds) versus insurance-first billing (PlushCare)—providing accurate expense estimates for diverse patient insurance situations.
Service Verification: Platform capabilities, medical team credentials, consultation formats, service scope, insurance networks, and clinical specialization evaluated through platform documentation, provider licensing verification, insurance acceptance research, and service model analysis. Assessment includes consultation format implications, specialty depth, primary care integration, and patient fit considerations.
Independence: This comparison receives no compensation from either platform and aims to provide evidence-based analysis helping patients select appropriate weight loss telehealth services based on insurance status, cost considerations, consultation format preferences, clinical complexity, and whether specialized weight loss focus or integrated primary care management better serves individual healthcare needs and coverage situations.
Final Verdict: Henry Meds vs PlushCare
Choose Henry Meds if: You are uninsured or your insurance does not cover weight loss medications, making cost optimization your priority with monthly costs of $197-297 representing substantial savings compared to insurance-excluded alternatives. You value specialized obesity medicine expertise with physicians focusing exclusively on GLP-1 therapy optimization and weight loss treatment. You are comfortable with asynchronous messaging consultations offering maximum scheduling flexibility without appointment constraints. You need only weight loss treatment without additional primary care services, and have established medical care for other conditions. You prioritize affordability and specialized clinical expertise over complete primary care integration, particularly if insurance does not cover weight loss services making cash-pay cost the determining factor.
Choose PlushCare if: You have good insurance coverage for telemedicine consultations and potentially GLP-1 medications, making copay-based access through insurance-accepting platform more affordable than cash-pay services. You prefer live video consultations with physicians providing real-time interactive dialogue over asynchronous messaging. You seek complete primary care services including weight management as one component of broader healthcare needs, or lack established primary care and need virtual medical home. You manage multiple health conditions benefiting from coordinated primary care oversight integrating obesity treatment with chronic disease management, mental health services, or preventive medicine. You value generalist physician coordination across diverse health concerns over specialized but isolated weight loss expertise, particularly if insurance coverage makes cost difference minimal.
Bottom line: Henry Meds and PlushCare represent fundamentally different telehealth models—Henry Meds offers specialized, cost-optimized GLP-1 access ($197-297/month) with asynchronous consultations and obesity medicine expertise serving uninsured or cash-pay patients through focused weight loss platform, while PlushCare provides complete primary care ($copay-dependent for insured, $299-549/month uninsured) with synchronous video consultations and generalist coordination integrating weight management with diverse healthcare services. For uninsured patients or those prioritizing specialized obesity medicine expertise and maximum cost efficiency, Henry Meds delivers superior value through dramatically lower costs, concentrated clinical specialization, and efficient asynchronous care delivery. For well-insured patients seeking complete primary care coordination, those preferring live video consultations, or individuals managing multiple health conditions requiring integrated oversight, PlushCare offers meaningful advantages through insurance acceptance, real-time physician interaction, and holistic healthcare management despite higher uninsured costs. The optimal choice depends critically on insurance status and coverage specifics (uninsured strongly favors Henry Meds; well-insured may favor PlushCare), service scope needs (isolated weight loss favors Henry Meds; complete primary care favors PlushCare), and consultation format preference (asynchronous messaging versus synchronous video) in your weight loss treatment approach.
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
